ALLMedicine™ Hepatitis E Center
Research & Reviews 1,066 results
Critical Care Nurse; Rose MQ, Santos CD et. al.
Aug 2nd, 2021 - Guillain-Barré syndrome precipitated by hepatitis E virus infection is rare, yet its incidence is increasing. A 57-year-old man was transferred from another facility with fatigue, orange urine, and progressive weakness over 4 to 6 weeks. Initial l...
World Journal of Gastroenterology; Veronese P, Dodi I et. al.
Jul 31st, 2021 - Hepatitis B virus (HBV) is the leading cause of chronic viral hepatitis. Annually, almost two million children younger than 5 years acquire the infection, mostly through vertical or horizontal transmission in early life. Vertical transmission of H...
The Journal of Infection; Wu J, Xiang Z et. al.
Jul 30th, 2021 - Hepatitis E virus (HEV) infection has many extrahepatic manifestations as well as liver symptoms. Multiple studies have shown that HEV infection has symptoms related to the nervous system, kidneys, cryoglobulinemia, hematological system, reproduct...
The International Journal of Artificial Organs; Ouji M, Taherkhani R et. al.
Jul 27th, 2021 - Hepatitis E virus (HEV) is one of the prevalent nosocomially transmitted agents among patients on maintenance hemodialysis due to parenteral transmission of HEV and immunocompromised condition of chronic hemodialysis patients. Therefore, this stud...
Infectious Diseases in Obstetrics and Gynecology; Sadeghi F, Golchob Z et. al.
Jul 27th, 2021 - Hepatitis A (HAV) and hepatitis E viruses (HEV) are endemic in Iran and are known major causes of acute viral hepatitis. Also, during pregnancy, they are associated with severe outcomes. Therefore, it is vital to evaluate the antibody levels again...
Clinicaltrials.gov 12 results
May 4th, 2020 - This study is a mono-center, randomization, double-blind clinical trial in healthy subjects between 18 to 50. Under the premise of full informed consent, 360 subjects that meet the requirement of clinical trial in the age of 18-50 will be divided ...
Apr 16th, 2019 - The purpose of the study is to compare the efficacy, safety and recurrence rate of two therapeutic strategies with ribavirin in patients with chronic hepatitis E and severe acute hepatitis E: fixed duration of treatment for 12 weeks vs variable du...
Mar 8th, 2019 - This is a single arm multicenter pilot study to provide preliminary evidence whether sofosbuvir (SOF) is efficacious and can be safely used in patients with chronic Hepatitis E virus infection.
Aug 9th, 2018 - Hepatitis E virus infection commonly presents as an acute self-limiting hepatitis in the developing world. However there have been reports that chronic hepatitis E may develop in immunocompromised subjects such as renal and liver transplant recipi...
Jul 19th, 2018 - This is a Phase III clinical trial of the novel recombinant HPV 16/18 bivalent vaccine manufactured by Xiamen Innovax Biotech CO., LTD. The primary objective of this study is to demonstrate the efficacy of the vaccine against relevant outcomes in ...
News 41 results
Jun 26th, 2018 - Many things can reactivate chronic hepatitis B virus (HBV) infection—withdrawal of antiviral therapy, pregnancy, and chemotherapy, to name a few. So when a patient with stable chronic HBV virus presented with significant hepatitis flare, clinician.
Apr 20th, 2018 - What is the hepatitis virus? Well, the hepatitis virus invades liver cells and causes inflammation in the liver tissue. Five hepatitis viruses are recognized: hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E. They all have sligh...
Nov 29th, 2017 - GENEVA (Reuters) - Hundreds of thousands of Rohingya refugees who fled from Myanmar into Bangladesh are at risk from a possible outbreak of diphtheria, the World Health Organization said in a report published on Tuesday. More than 620,000 people f...
Aug 1st, 2017 - Q2: Answer: B This patient has chronic hepatitis E infection, as demonstrated by the positive hepatitis IgG antibody. It is recommended that HEV RNA be identified in serum or stool for diagnosis of hepatitis E.
Deepak Chitnis, MDedge News
Sep 12th, 2016 - While real-time polymerase chain reaction (PCR) testing is the standard test for hepatitis E virus infection, an anti-HEV-specific enzyme-linked immunosorbent assay (ELISA) is more effective than is PCR at distinguishing between acute and chronic.